Trexquant Investment LP Global Blood Therapeutics, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$22.3 - $37.39 $102,312 - $171,545	-4,588 Reduced 40.75%	6,672 $213,000
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $402,200 - $557,410	-15,662 Reduced 58.18%	11,260 $390,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $467,597 - $756,042	18,779 Added 230.62%	26,922 $788,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $207,483 - $304,059	8,143 New	8,143 $207,000
Q2 2021 Aug 12, 2021	SELL	$32.46 - $43.42 $257,959 - $345,058	-7,947 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $291,894 - $381,171	-7,496 Reduced 48.54%	7,947 $324,000
Q4 2020 Feb 11, 2021	BUY	$37.65 - $63.77 $129,290 - $218,986	3,434 Added 28.6%	15,443 $669,000
Q3 2020 Nov 06, 2020	SELL	$52.76 - $74.49 $83,677 - $118,141	-1,586 Reduced 11.67%	12,009 $662,000
Q2 2020 Aug 07, 2020	BUY	$48.73 - $81.82 $234,196 - $393,226	4,806 Added 54.68%	13,595 $858,000
Q1 2020 May 08, 2020	BUY	$41.72 - $87.2 $366,677 - $766,400	8,789 New	8,789 $449,000
Q2 2019 Aug 09, 2019	SELL	$52.6 - $63.29 $593,275 - $713,847	-11,279 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$39.99 - $53.48 $451,047 - $603,200	11,279 New	11,279 $597,000
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $1.1 Million - $1.63 Million	-34,966 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$38.0 - $51.1 $1.16 Million - $1.56 Million	30,540 Added 690.01%	34,966 $1.33 Million
Q2 2018 Aug 07, 2018	SELL	$38.7 - $50.15 $1.04 Million - $1.34 Million	-26,759 Reduced 85.81%	4,426 $200,000
Q1 2018 May 03, 2018	BUY	$39.6 - $65.9 $1.23 Million - $2.06 Million	31,185 New	31,185 $1.51 Million
Q4 2017 Feb 09, 2018	SELL	$29.7 - $45.7 $193,584 - $297,872	-6,518 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$25.1 - $31.05 $163,601 - $202,383	6,518	6,518 $202,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account